Autopsy report · NCT04558034

The Use of Cryotherapy to Prevent Paclitaxel-induced Peripheral Neuropathy and Nail Changes in Women With Breast Cancer

“Principal Investigator retired before study completed.”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 6 months before it stopped.
• 14 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Parkview Health

Sponsor type

University, hospital or other

Conditions

Cryotherapy Effect; Peripheral Neuropathy; Nail Toxicity

Interventions

cryotherapy

Participants

14

Sites

1

Countries

United States

Trials that died the same way

• Target Sign vs Palpation for Radial Arterial Line Placement
  “Principal Investigator retired” (90% match in meaning)
• HCV Treatment With Fluvastatin, Simvastatin to Improve Interferon Sensitivity
  “Principal Investigator retiring” (87% match in meaning)
• Nutraceuticals Versus Usual Care in the Prevention or Reduction of CIPN in Patients Treated With Docetaxel as Neoadjuvant/Adjuvant Breast Cancer Therapy
  “Retirement of the Principal Investigator” (85% match in meaning)
• Brain Function in Depression and Insulin Resistance
  “Principal Investigator Left University” (77% match in meaning)
• Effects of Pregnenolone on Perceived Social Isolation
  “Principal Investigator left institution.” (76% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.